β-Blockers as initial therapy for hypertension.
暂无分享,去创建一个
[1] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.
[2] Yuan-sheng Gao,et al. Beta blockers, nitric oxide, and cardiovascular disease. , 2013, Current opinion in pharmacology.
[3] A. Lewin,et al. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial. , 2013, Clinical therapeutics.
[4] J. Cruickshank. β blockers in hypertension , 2010, The Lancet.
[5] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.
[6] Falk Hoffmann. β-Blockers for hypertension , 2007, Canadian Medical Association Journal.
[7] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[8] Ross Ward,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure , 2011 .
[9] L. Opie,et al. β-Blocking Agents , 2009 .
[10] L. Opie. Drugs for the Heart , 1981 .